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Coronavirus disease, COVID-19 (coronavirus disease 
2019), caused by SARS-CoV-2 (severe acute respiratory 
syndrome coronavirus 2), has a higher case fatality rate in 
European countries than in others, especially East Asian 
ones. One potential explanation for this regional difference 
is the diversity of the viral infection efficiency. Here, we 
analyzed the allele frequencies of a nonsynonymous variant 
rs12329760 (V197M) in the TMPRSS2 gene, a key enzyme 
essential for viral infection and found a significant association 
between the COVID-19 case fatality rate and the V197M 
allele frequencies, using over 200,000 present-day and 
ancient genomic samples. East Asian countries have higher 
V197M allele frequencies than other regions, including 
European countries which correlates to their lower case 
fatality rates. Structural and energy calculation analysis of the 
V197M amino acid change showed that it destabilizes the 
TMPRSS2 protein, possibly negatively affecting its ACE2 and 
viral spike protein processing.
Keywords: allele frequency, case fatality rate, COVID-19, 
SARS-CoV-2, TMPRSS2 
INTRODUCTION
COVID-19 (coronavirus disease 2019) is an infectious disease 
caused by SARS-CoV-2 (severe acute respiratory syndrome 
coronavirus 2). Appearing first during late 2019 in Wuhan, 
China, COVID-19 has spread rapidly worldwide (Lai et al., 
2020). As of May 23, 2020, SARS-CoV-2 has infected >5 mil-
lion people in over 200 countries, killing more than 330,000 
people (European Centre for Disease Prevention and Con-
trol, 2020). Many European countries had been particularly 
affected, with Spain and Italy each having reached over 
200,000 cases of infection and more than 27,000 deaths, 
reaching a maximum case fatality rate (CFR) of >10% (Eu-
ropean Centre for Disease Prevention and Control, 2020). In 
contrast, many East Asian countries did not experience such 
dire effects, with South Korea, for instance, reporting a peak 
CFR of 2.4% (European Centre for Disease Prevention and 
Control, 2020). Multiple contributing factors could explain 
this difference, including timing and severity of lockdown 
measures (Sonn et al., 2020), population age ratio (Dowd 
et al., 2020), healthcare resource availability (Ji et al., 2020), 
smoking rate (Cai, 2020a; 2020b), and early tuberculosis (Ba-
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cillus Calmette–Guérin) vaccination (Hussein, 2020; Miller et 
al., 2020; Redelman-Sidi, 2020). In principle, genetic factors 
may also underpin differential susceptibility to SARS-CoV-2 
(Cao et al., 2020; Williams et al., 2020; Yuan et al., 2014).
 Genes encoding cellular serine protease (TMPRSS2), an-
giotensin-converting enzyme 2 (ACE2), cysteine proteases 
cathepsin B and cathepsin L (CatB, CatL), phosphatidylinositol 
3-phosphate 5-kinase (PIKfyve), and two pore channel sub-
type 2 (TPC2) are notable for their critical roles in SARS-CoV-2 
infection (Hoffmann et al., 2020; Ou et al., 2020). Particular-
ly, the virus utilizes TMPRSS2 and CatB/L proteolytic activity 
for priming the viral spike protein, whereas ACE2 is the entry 
receptor for breaking into host cells (Hoffmann et al., 2020; 
Ou et al., 2020). A study has suggested TMPRSS2 inhibition 
as a clinical target because the priming step is a key factor de-
termining successful entry into target cells (Hoffmann et al., 
2020). Most of the recent publications on the SARS-CoV-2 
susceptibility so far focused on ACE2 and TMPRSS2 as possi-
ble genetic determinants by analyzing their associations with 
sex hormones, their gene expression in various tissues and 
cell lines, and interactions with spike protein or inhibitors at a 
gene level (Hoffmann et al., 2020; Matsuyama et al., 2020; 
Mjaess et al., 2020; Song et al., 2020; Zhou et al., 2020).
  To understand the genetic background of complex phe-
notypes in human populations, researchers commonly assess 
correlations with allele frequency (AF) (Asselta et al., 2020; 
Das and Ghate, 2020). This approach has identified a cor-
relation between ancestral genetic composition and the CFR 
of COVID-19 (Das and Ghate, 2020). However, few have 
examined specific variants, their frequencies and individual 
contributions to SARS-CoV-2 susceptibility. Some reports 
are also based only on low-resolution intercontinental com-
parisons between Europeans and East Asians (Asselta et al., 
2020; Das and Ghate, 2020; Kenyon, 2020). Based on these 
studies, not only do TMPRSS2 variants appear to have wide 
population-specific variation (Asselta et al., 2020), but, TM-
PRSS2 also has low mutation burden in certain populations, a 
characteristic that could partially explain high TMPRSS2 gene 
expression. Consequently, the latter is associated with a poor 
outcome in COVID-19 (Asselta et al., 2020). Moreover, we 
know little about the evolutionary history of SARS-CoV-2 sus-
ceptibility-associated variants, including when they occurred 
or how their frequencies might have changed over time.
 In this study, we investigated intercountry AF differences 
of TMPRSS2 variants, estimated variant effects on TMPRSS2 
protein structural stability, and linked them to the average 
of time-adjusted COVID-19 CFR (AT-CFR) using the method 
described in (Daneshkhah et al., 2020); and Materials and 
Methods section. We propose that the structural deviation 
causes TMPRSS2 to be less stable, resulting in a reduced over-
all infection rate that led to the reduced CFR in East Asians. 
We collected and analyzed 221,498 genomes from public 
databases (Cocca et al., 2020; Urnikyte et al., 2019; Zhang 
et al., 2019) and 2,262 whole genomes from the Korean 
Genome Project (Jeon et al., 2020). We also traced TMPRSS2 
AF distribution in ancient populations by region and time 
period. We aimed to increase the current understanding of 
the genetic variation underlying SARS-CoV-2 infections and 
explain the regional differences in the CFR.
MATERIALS AND METHODS
Variant selection and data collection
Autosomal nonsynonymous variants located in TMPRSS2 
were extracted from Korea2K variome set (n = 2,262) from 
the Korean Genome Project (Jeon et al., 2020), which turned 
out to contain 15 single nucleotide variants (SNVs). Alterna-
tive AFs of other populations were obtained from the PGG.
SNV database (GRCh38) (n = 220,147) (Zhang et al., 2019), 
Italian Genome Reference Panel (IGRP1.0) (n = 926) (Cocca 
et al., 2020), and Lithuanian high density SNV data (n = 425) 
(Urnikyte et al., 2019). IGRP1.0 and Lithuanian genomes 
were lifted over to hg38 coordinates in Picard version 2.22.3 
(Broad Institute, 2020), using LiftoverVcf with default op-
tions. The combined dataset included 223,760 samples from 
4 variome databases with whole-genome sequencing, exome 
sequencing, or genotyping chip data (Supplementary Data 
S1). Allele counts were merged based on country of sample 
origin.
 Populations were excluded if they could not be assigned 
to any specific country, if had fewer than 2,500 reported 
COVID-19 cases, or when AF or CFR information was un-
available. Nonsynonymous variants were included only if they 
were present in >10 countries and had a global AF of >1%. 
The final dataset used to calculate AF and CFR correlations 
contained 72,907 samples (from 29 countries) for TMPRSS2 
V197M.
Correlation with average case fatality rate (AT-CFR)
We downloaded COVID-19 data set on March 22, 2021 from 
Our World in Data (https://github.com/owid/covid-19-data/
tree/master/public/data). We employed the equation from 
Daneshkhah et al. (2020), to calculate time-adjusted CFR 
(T-CFR) (Equation 1), which throughout this manuscript is 
averaged and referred to as AT-CFR.
 (Equation 1)
where N is the number of days which showed <2,500 con-
firmed cases on each country, an is a weight of T-CFR on day 
n, T-CFRn is T-CFR on day n, ci is the number of confirmed 
cases at day i.
 Spearman’s correlation test was conducted between AF 
and AT-CFR in R version 3.5.1.
Variant annotation
Variants were annotated in VEP version 99.2 (McLaren et al., 
2016) with dbNSFP version 3.0 (Liu et al., 2016) to evaluate 
deleteriousness and conservation. Additionally, phastCons 
scores were obtained for primates, mammals, and verte-
brates to determine interspecies conservation of significant 
variant sites.
TMPRSS2 protein structure modelling and variant effects 
on the protein structure
We built a TMPRSS2 model using hepsin (1Z8G) as the tem-
plate structure. The model was selected using PSI-BLAST 
sequence search (Altschul et al., 1997), along with alignment 
from NCBI. Two sets of TMPRSS2 models were generated 
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using the Robetta web server (Kim et al., 2004) and I-TASS-
ER (Yang et al., 2015): a wild-type TMPRSS2 model based 
on 1Z8G and a V197M mutant model based on the wild-
type one. Valine of residue 65 of 1Z8G was also substituted 
with methionine to generate mutant type. Protein energies 
of wild-type and variant models were compared in dDFIRE 
(Yang and Zhou, 2008) and nDOPE (Shen and Sali, 2006) to 
determine structural stability (details in the Supplementary 
Methods). dDFIRE (Yang and Zhou, 2008) scores have been 
extracted from the protein structure based on the distance 
between two atoms and the three angles involved in the 
dipole-dipole interaction. nDOPE (Shen and Sali, 2006) was 
used to measure protein energy as a statistical potential 
dependent on the calculated atomic distance in the protein 
structure.
 Ramachandran favorable regions were measured through 
MolProbity (Williams et al., 2018). The following tools were 
used to predict variation in TMPRSS2 protein stability for both 
wild-type and mutant-type models: PoPMuSiC (Dehouck et 
al., 2011), CUPSAT (Parthiban et al., 2006), I-Mutant3 (Cap-
riotti et al., 2008), DUET (Pires et al., 2014a), mCSM (Pires et 
al., 2014b), SDM (Pandurangan et al., 2017), MuPro (Cheng 
et al., 2006). Visualizations were created in UCSF Chimera 
(Pettersen et al., 2004).
Ancient genome allele frequency analysis
Ancient genomes were downloaded from the David Reich 
Lab (https://reich.hms.harvard.edu/datasets; Supplemen-
tary Data S2 and S3). Additional ancient European data for 
V197M (rs12329760) were obtained from the PGG.SNV 
database. Data format conversion was handled using PLINK 
version 1.9 (Chang et al., 2015). Presence of the two vari-
ants was verified and their frequencies calculated in different 
ancient populations (Supplementary Data S2-S4). Temporal 
variation in AF was visualized using the ggplot2 package in R.
RESULTS
Correlation of nonsynonymous TMPRSS2 allele frequen-
cies with COVID-19 AT-CFR 
We found two nonsynonymous exonic TMPRSS2 variants 
(V197M, rs12329760; G8V, rs75603675) of which V197M 
AF was significantly correlated with COVID-19 AT-CFR 
(Spearman’s correlation ρ = –0.482, P = 0.00881 for V197M) 
(Fig. 1B). Even though the COVID-19 AT-CFR has been stabi-
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Fig. 1. COVID-19 AT-CFR correlation with allele frequencies of TMPRSS2 V197M (rs12329760) variant based on 29 countries. (A) 
COVID-19 AT-CFR dynamics in 29 countries from December 31, 2019 to March 22, 2021. (B) Correlation plot of TMPRSS2 V197M allele 
frequencies with COVID-19 AT-CFR. (C) Correlation plot of TMPRSS2 V197M allele frequencies with COVID-19 AT-CFR-100 (day 347-
447, purple color in panel A). The size of dots indicates the proportion of people who are 70 or older in the countries. The correlations 
were estimated by Spearman’s correlation test. (D) Allelic odds ratios (OR; 100 Genomes Project Consortium, 2010) (i.e., alternative/
reference allele counts) of the Y-axis country to the X-axis country are presented in for V197M variant. Countries are color-coded by the 
region abbreviation. AFR, Africa; CA, Central Asia; EU, Europe; SEA, Southeast Asia; AMR, Americas; EA, East Asia; SA, South Asia; WA, 
West Asia. Full country names and allele frequencies per country are in Supplementary Data S5.
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ple), we found a significant correlation between the regional 
V197M AF and the average of CFR for the last 100 days as 
well (AT-CFR-100; Spearman’s correlation ρ = –0.435, P = 
0.0192) (Fig. 1C). The V197M AF correlation with infection 
rate, which is presented as total COVID-19 cases per million 
individuals was less significant (infection rate, Spearman’s 
correlation ρ = –0.39, P = 0.0375) (Supplementary Fig. S1). 
Contrary to the V197M, we could not find a significant cor-
relation between G8V’s regional AF and both AT-CFR and 
AT-CFR-100 (Spearman’s correlation; AT-CFR: ρ = 0.358, P = 
0.133 and AT-CFR-100: ρ = 0.139, P = 0.57) (Supplementary 
Fig. S2), therefore it was removed from the following anal-
yses. These two variants were present among 20 TMPRSS2 
exonic variants with AF of >1% in gnomAD (Karczewski et 
al., 2020). Thirteen of these were in 3′ UTR, remaining five 
were synonymous (Supplementary Fig. S3, Supplementary 
Data S6). G8V is located in a cytoplasmic domain with an 
undetermined 3D structure (Supplementary Fig. S4). V197M 
is located in a stable beta-sheet of the scavenger receptor 
cysteine-rich (SRCR) domain (Supplementary Fig. S4, Fig. 2).
Correlation between TMPRSS2 V197M allele frequency 
and COVID-19 AT-CFR 
The AF of V197M was negatively correlated with COVID-19 
AT-CFR and AT-CFR-100 (Figs. 1B and 1C). The AF distri-
bution pattern was consistent with previous reports, with 
V197M AF being significantly lower in most Europeans than 
in East Asians (Asselta et al., 2020) (Fig. 1D, Supplementary 
Data S5 and S7). In Chinese, Japanese, and Koreans, AF was 
34.5%, 38.8%, and 36.8%, respectively (Supplementary 
Data S5). Among Europeans, the Finnish were a surprising 
outlier, with 37.3% AF (vs 19.9% in Italians, 17.8% in Span-
ish, and 22.6% in British) that corresponded to a low AT-CFR 
(Supplementary Data S5). Finnish AF significantly differed 
only from the Chinese population among East Asians (P = 
3.61 × 10
–3) (Supplementary Fig. S5). West Asians have AF 
that are similar to or lower than Europeans (Turkey 17.1%, 
Israel 13.2%). Latin Americans in general exhibited the low-
est AFs, ranging from 18.8% in Columbia to 6.5% in Peru 
(Supplementary Data S5, Supplementary Fig. S5). Peruvian 
AF differed from all other countries except Mexico and Alge-
ria (Supplementary Fig. S5, Supplementary Data S5).
TMPRSS2 V197M allele is archaic in humans
We also found that V197M occurred in an extremely 
well-conserved position (phastCons17way_primate: 0.958, 
Supplementary Data S8) of the SRCR domain, suggesting 
that it is under purifying selection. Moreover, functional pre-
diction tools SIFT (Ng and Henikoff, 2003) and PolyPhen2 
(Adzhubei et al., 2010) regarded the variant as “deleterious” 
and “probably damaging”, respectively (Supplementary Data 
S8). This led us to investigate its selection in great apes and 
archaic hominin genomes.
 Interestingly, the V197M variant is absent in the great apes 
(Han et al., 2019; Prado-Martinez et al., 2013) and in all se-
quenced archaic hominin genomes (Denisovan, Neanderthal) 
(Supplementary Data S9). We further investigated presence 
of V197M variant in ancient human genomes. Tianyuan 
man’s genotype showed that the variant was already present 
in humans 40,000 years ago in East Asia (Supplementary 
Data S3). We also found V197M in ancient genomes I7021 
and I13180 from Mongolia, dated 5,211-5,000 BCE and 
3,013-2,876 BCE, respectively (Supplementary Data S2). 
Starting from the pre-Ice Age (34,000-26,000 years ago), 
the variant was present in European inhabitants (37,250 
BCE sample GoyetQ116-1 from Belgium [Fu et al., 2016]) 
and remained ever since (Supplementary Data S2 and S4). 
Although small sample sizes precluded statistical analysis, 
Fig. 2. TMPRSS2 protein structure of both wild type (V197) and 
mutant type (M197), predicted with homology modeling using 
hepsin (1Z8G) template from the PDB database.
Table 1. Effect of V197M variant on structural features
Modeled structure Type of structures dDFIRE nDOPE
Ramachandran  
plot (favored) (%)
Hepsin (1Z8G) V197d –822.28 –1.586 97.53
M197e –812.80 –1.439 96.76
Robettaa TMPRSS2 (SRCR)b V197 –183.43 –1.125 94.68
M197 –176.48 –0.907 93.62
TMPRSS2 (SRCR + peptidase S1)c V197 –730.79 –1.135 94.77
M197 –725.40 –1.062 93.90
I-TASSERa TMPRSS2 (SRCR) V197 –184.17 –0.909 91.67
M197 –151.16 –0.156 86.17
TMPRSS2 (SRCR + peptidase S1) V197 –700.23 –0.704 92.44
M197 –615.98 –0.129 86.05
aHomology modeling tools, bSRCR domain separated from modeled TMPRSS2 structure, cModeled TMPRSS2 structure, dWild type (V197) 
structure, eMutant type structure with M197 variant.
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V197M AF appeared to be higher in ancient East Asian pop-
ulations (33.3%) than in ancient Europeans (16.3%) (Sup-
plementary Data S3 and S4, Supplementary Fig. S6).
Effect of V197M variant on TMPRSS2 protein structure
We used 3D protein models to investigate the effect of 
V197M on TMPRSS2. V197M increased energy score more 
than wild type (Table 1), suggesting reduced stability. Two 
programs (dDFIRE [Yang and Zhou, 2008], nDOPE [Shen and 
Sali, 2006]) were used to measure the effect of V197M on 
the protein.
 We used two homology modeling tools (Robetta [Kim 
et al., 2004], I-TASSER [Yang et al., 2015]) (Supplementa-
ry Methods) and transmembrane serine protease hepsin 
(PDB ID 1Z8G chain A) (Herter et al., 2005) as the template 
(Supplementary Fig. S7). The resultant model contains both 
SRCR and nearby peptidase S1 domains of TMPRSS2 (Fig. 
2) because the former was too small for modeling. Despite 
only minor structural changes to the SRCR domain (Fig. 2), 
V197M had a consistently destabilizing effect in TMPRSS2 
(Table 1). A further indication of reduced stability in mutants 
was a decrease in the favored region of the Ramachandran 
plot. Seven computational protein-stability prediction tools 
confirmed the V197M variant as destabilizing (Supplementa-
ry Data S10).
DISCUSSION
This study has limitations. First, we only used public genome 
databases and variant frequency data that are not directly 
linked to COVID-19 patients and the CFR. However, a recent 
study conducted on COVID-19 patients in Italy confirmed 
V197M allele frequencies appear to be correlated to patients’ 
clinical outcomes (Monticelli et al., 2021). Furthermore, we 
could not completely normalize AT-CFR with relevant covari-
ates, such as lockdown measures, mask availability, medical 
care standards, within-population or within-fatal-case age 
ratios, and SARS-CoV-2 test availability. However, we tested 
the Spearman’s correlation between AT-CFR and thirteen so-
cio-economic variables such as population density and Gross 
Domestic Product (GDP) per capita in a pairwise manner and 
found that only the population density had significant pos-
itive correlations (Supplementary Figs. S8 and S9). Another 
limitation is the lack of variant frequency data on chromo-
some X, absent from many public databases such as PGG.
SNV, even though the X chromosome contains a key player, 
ACE2 (Hoffmann et al., 2020; Ou et al., 2020). Notably, our 
protein structure modeling showed that TMPRSS2 and the 
template had a low sequence identity (32.49%). However, 
we confirmed that the V197M variant region of SRCR re-
mained extremely consistent (Fig. 2, Supplementary Fig. S7).
 A previous report has noted that Europeans have signifi-
cantly lower V197M AF than East Asians, a pattern speculat-
ed to be associated with COVID-19 CFR (Asselta et al., 2020). 
To confirm that this association in our study had not occurred 
by chance, we performed a V197M AF correlation test based 
on two different approaches (the correlation with AT-CFR 
and correlation with AT-CFR-100) applying multiple input 
filtering criteria (Supplementary Figs. S10-S12) as well as a 
series of linear regression analyses considering publicly avail-
able regional socio-economic and epidemiological variables 
(Supplementary Data S11-S16). Although we observed a 
very significant correlation between the AFs of the TMPRSS2 
V197M variant and AT-CFR (Fig. 1), correlation between AF 
and infection cases per million individuals was less-significant 
(29 countries, Spearman’s correlation, ρ = –0.39, P = 0.0375) 
(Supplementary Fig. S1). One likely explanation is that infec-
tion cases are a more complex parameter than CFR. Factors 
such as high altitude had been reported to affect infection 
rate while not affecting CFR in COVID-19 (Segovia-Juarez et 
al., 2020). Alternatively, CFR in infectious diseases reflects the 
importance of genetic factors more than infection rate (Pe-
tersen et al., 2010). One example, could be a study that eval-
uated the incidence and CFR in sixteen yellow fever epidemics 
and found no significant differences between the infection 
rates of Caucasians and non-Caucasians while CFR differed 
significantly. Moreover, the study was unable to explain the 
differences observed by socioeconomic or demographic fac-
tors, or acquired immunity (Blake and Garcia-Blanco, 2014). 
To verify such trends in COVID-19, we require further studies 
investigating genomes, infection, treatment, and CFR data of 
COVID-19 patients.
 Our evaluation of protein structural stability predicted that 
V197M destabilizes TMPRSS2 (Table 1, Supplementary Data 
S10). We suspect V197M variant to be related to the overall 
TMPRSS2 gene expression; however, we could not validate 
it.
 In line with previous reports, we suggest that V197M acts 
to indirectly compromise the binding affinity of TMPRSS2 
to SARS-CoV-2 spike protein and ACE2 (Bhattacharyya et 
al., 2020; Petersen et al., 2010; Sharma et al., 2020). This 
implies a protective role of the V197M variant against SARS-
CoV-2 infections, but neither we nor previous researchers 
(Bhattacharyya et al., 2020; Paniri et al., 2021; Sharma et 
al., 2020) have uncovered any clear evidence or explanation 
for causation. Interestingly, the change from valine to me-
thionine has a Grantham distance matrix value of only 22, 
the shortest distance from valine to any amino acid. Thus, 
V197M may lie on a thin boundary of extreme conservation 
versus functional benefit that may have arisen through the 
viral invasion and polymorphisms in different ethnic groups 
that caused 3D structural deviation. We speculate that East 
Asians have already experienced similar viral infections in the 
past (Souilmi et al., 2020), leading to natural selection on 
V197M in TMPRSS2. However, our results do not disprove 
the alternative evolutionary mechanisms. The genetic drift 
due to population migrations and admixtures, and selection 
on TMPRSS2 by unknown evolutionary drivers may result in 
the AF differences. Regardless of the underlying mechanisms 
that caused AF differences, our AT-CFR and the genetic AF 
correlation study suggests that East Asians may have some 
genetic resistance that is reflected in the 3D structure of TM-
PRSS2 that negatively affects infection efficiency and hence 
the CFR of COVID-19.
 Notably, the majority of the data in our study were ob-
tained from PGG.SNV database (Zhang et al., 2019) (Sup-
plementary Data S1), where we cannot check the duplicity as 
the genome data for each sample is not available, only allele 
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counts. This also complicates checking duplicity between the 
PGG.SNV (Zhang et al., 2019) and the external data used 
(such as Korean [Jeon et al., 2020], Lithuanian [Urnikyte et 
al., 2019], and Italian data [Cocca et al., 2020]) (Supplemen-
tary Data S1). Duplicity could have possibly occurred as the 
same individual could have been sequenced or genotyped for 
multiple projects either within PGG.SNV database, or for e.g., 
PGG.SNV and Korea1K. Still, the chances of this happening 
must be very low and even if it is the case, it would not affect 
the overall statistics significantly.
Note: Supplementary information is available on the Mole-
cules and Cells website (www.molcells.org).
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